Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2009-08-21 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: EVRY-COURCOURONNES (91000), Essonne
PHARMACIE JOUVENCY : revenue, balance sheet and financial ratios
PHARMACIE JOUVENCY is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in EVRY-COURCOURONNES (91000),
this company of category PME
shows in 2021 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JOUVENCY (SIREN 514366814)
Indicator
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 558 416 €
1 492 181 €
1 330 334 €
1 243 026 €
1 369 285 €
1 425 607 €
Net income
184 148 €
80 578 €
83 523 €
68 801 €
44 356 €
54 164 €
57 871 €
EBITDA
N/C
98 239 €
110 127 €
86 103 €
68 964 €
86 247 €
98 675 €
Net margin
N/C
5.2%
5.6%
5.2%
3.6%
4.0%
4.1%
Revenue and income statement
In 2023, PHARMACIE JOUVENCY generates positive net income of 184 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 58 k€ -> 184 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
184 148 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 141%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
140.852%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.686%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
Debt ratio
60.592
47.156
36.219
25.359
10.428
3.358
140.852
Financial autonomy
58.645
64.733
70.299
75.954
84.577
90.765
35.686
Repayment capacity
7.063
6.179
5.951
3.474
1.359
0.381
None
Cash flow / Revenue
5.204%
5.122%
4.595%
5.399%
5.737%
4.882%
None%
Sector positioning
Debt ratio
140.852023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+43 pts over 3 years
In 2023, the debt ratio of PHARMACIE JOUVENCY (140.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.69%2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-44 pts over 3 years
In 2023, the financial autonomy of PHARMACIE JOUVENCY (35.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.38 years2021
2020
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Excellent
In 2021, the repayment capacity of PHARMACIE JOUVENCY (0.38) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 251.07. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
251.07
Liquidity indicators evolution PHARMACIE JOUVENCY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
Liquidity ratio
330.06
357.916
301.823
249.558
178.033
168.38
251.07
Interest coverage
18.002
15.131
16.929
9.753
6.591
6.062
None
Sector positioning
Liquidity ratio
251.072023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good+21 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE JOUVENCY (251.07) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
6.06x2021
2020
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Excellent+10 pts over 2 years
In 2021, the interest coverage of PHARMACIE JOUVENCY (6.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JOUVENCY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
Operating WCR
129 873 €
110 967 €
133 861 €
111 469 €
88 546 €
90 186 €
0 €
Inventory turnover (days)
29
28
32
27
26
23
0
Customer payment term (days)
6
6
6
6
4
6
0
Supplier payment term (days)
17
12
16
15
13
12
0
Positioning of PHARMACIE JOUVENCY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE JOUVENCY is estimated at
2 172 849 €
(range 1 321 414€ - 3 054 539€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1321k€2172k€3054k€
2 172 849 €Range: 1 321 414€ - 3 054 539€
NAF 5 année 2023
Valuation method used
Net Income Multiple
184 148 €
×
11.8x
=2 172 850 €
Range: 1 321 414€ - 3 054 539€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JOUVENCY with other companies in the same sector:
Frequently asked questions about PHARMACIE JOUVENCY
What is the revenue of PHARMACIE JOUVENCY ?
The revenue of PHARMACIE JOUVENCY in 2021 is 1.6 M€.
Is PHARMACIE JOUVENCY profitable?
Yes, PHARMACIE JOUVENCY generated a net profit of 184 k€ in 2023.
Where is the headquarters of PHARMACIE JOUVENCY ?
The headquarters of PHARMACIE JOUVENCY is located in EVRY-COURCOURONNES (91000), in the department Essonne.
Where to find the tax return of PHARMACIE JOUVENCY ?
The tax return of PHARMACIE JOUVENCY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JOUVENCY operate?
PHARMACIE JOUVENCY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart